Which corticosteroid is commonly prescribed for asthma control?

Fluticasone is a corticosteroid commonly prescribed for asthma control because it helps reduce inflammation in the airways, which is a key factor in asthma management. By decreasing airway inflammation, fluticasone can help alleviate symptoms such as wheezing, shortness of breath, and coughing, while also improving overall lung function. Corticosteroids like fluticasone are often part of a long-term management plan for asthma, particularly for patients who experience frequent exacerbations or need consistent control of their symptoms.

Mast cell stabilizers, like those mentioned in the first option, are not corticosteroids and work differently by preventing the release of histamine and other inflammatory substances from mast cells. Montelukast is a leukotriene receptor antagonist that helps manage asthma by blocking substances that lead to airway inflammation, albeit not having the anti-inflammatory effect of corticosteroids. Albuterol, while effective as a bronchodilator for quick relief, does not address the underlying inflammation associated with asthma, making it less suitable for long-term management compared to corticosteroids like fluticasone.